Real‐World Assessment of Trilaciclib for the Prevention of Chemoradiotherapy‐Induced Myelosuppression in Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study.
Saved in:
| Title: | Real‐World Assessment of Trilaciclib for the Prevention of Chemoradiotherapy‐Induced Myelosuppression in Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study. |
|---|---|
| Authors: | Yan, Jingze1 (AUTHOR), Liu, Zeyuan2,3 (AUTHOR), Chen, Hui1 (AUTHOR), Sun, Xinchen1 (AUTHOR), Ge, Xiaolin1 (AUTHOR) doctorxlg@163.com, Xia, Xiaojie1 (AUTHOR) doctorxiaxiaojie@163.com |
| Source: | Cancer Medicine. Apr2025, Vol. 14 Issue 8, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.70862 |
